{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:71818"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:71818","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Venous thrombosis and women's health: Identification of risk factors and long terms effects","abstract":"Venous thromboembolism (VTE) remains an important cause of morbidity and mortality, with well-recognised inherited and acquired risk factors. Women are particularly at risk of this condition because of pregnancy, the use of combined oral contraceptive pills, and hormone replacement therapy. A number of long-term sequelae may occur following an episode of VTE in women, such as development of the post- thrombotic syndrome, restriction of future contraceptive choice, bleeding events related to anticoagulants, and recurrence of thrombosis. In recent years there has been a marked increase in our understanding of genetic risk factors important for the development of VTE, and of their interaction with acquired risks. In particular, the description of the factor V Leiden and (more recently) prothrombin 202 lOA mutations have highlighted common genetic variations that are associated with a modest increased risk of thromboembolism. These genetic mutations may also be associated with other conditions that are associated with coagulation activation, such as preeclampsia. Thrombophilia is a rapidly expanding and complex field, and undoubtedly new abnormalities will be described within the next few years.","abstract_html":"Venous thromboembolism (VTE) remains an important cause of morbidity and mortality, with well-recognised inherited and acquired risk factors. Women are particularly at risk of this condition because of pregnancy, the use of combined oral contraceptive pills, and hormone replacement therapy. A number of long-term sequelae may occur following an episode of VTE in women, such as development of the post- thrombotic syndrome, restriction of future contraceptive choice, bleeding events related to anticoagulants, and recurrence of thrombosis. In recent years there has been a marked increase in our understanding of genetic risk factors important for the development of VTE, and of their interaction with acquired risks. In particular, the description of the factor V Leiden and (more recently) prothrombin 202 lOA mutations have highlighted common genetic variations that are associated with a modest increased risk of thromboembolism. These genetic mutations may also be associated with other conditions that are associated with coagulation activation, such as preeclampsia. Thrombophilia is a rapidly expanding and complex field, and undoubtedly new abnormalities will be described within the next few years.","abstract_has_math":false,"creators":["McColl, Mark D."],"institution":"University of Glasgow","degree_name":null,"degree_level":"MD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1999,"date_issued":"1999","date_published":"1999","updated_at":"2026-11-19T08:27:26Z","subjects":["QP Physiology"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.5525/gla.thesis.71818","outbound_label":"DOI","outbound_source":"dc:identifier.doi","record_url":"https://doi.org/10.5525/gla.thesis.71818","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier.doi","download_url":"https://theses.gla.ac.uk/71818/1/10391478.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A71818","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["McColl, Mark D."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["1999"]},{"key":"dc:date.issued","label":"Date","values":["1999"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Department not provided."]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/71818/"]},{"key":"dc:relation.isreferencedby.uri","label":"Dc Relation Isreferencedby URI","values":["https://gla.on.worldcat.org/oclc/181725192"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["MD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QP Physiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.5525/gla.thesis.71818"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/71818/1/10391478.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Venous thromboembolism (VTE) remains an important cause of morbidity and mortality, with well-recognised inherited and acquired risk factors. Women are particularly at risk of this condition because of pregnancy, the use of combined oral contraceptive pills, and hormone replacement therapy. A number of long-term sequelae may occur following an episode of VTE in women, such as development of the post- thrombotic syndrome, restriction of future contraceptive choice, bleeding events related to anticoagulants, and recurrence of thrombosis. In recent years there has been a marked increase in our understanding of genetic risk factors important for the development of VTE, and of their interaction with acquired risks. In particular, the description of the factor V Leiden and (more recently) prothrombin 202 lOA mutations have highlighted common genetic variations that are associated with a modest increased risk of thromboembolism. These genetic mutations may also be associated with other conditions that are associated with coagulation activation, such as preeclampsia. Thrombophilia is a rapidly expanding and complex field, and undoubtedly new abnormalities will be described within the next few years."]},{"key":"dc:format","label":"Dc Format","values":["pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Venous thrombosis and women's health: Identification of risk factors and long terms effects"]}]}],"canonical_facts":{"dc:creator":["McColl, Mark D."],"dc:date":["1999"],"dc:date.issued":["1999"],"dc:description.abstract":["Venous thromboembolism (VTE) remains an important cause of morbidity and mortality, with well-recognised inherited and acquired risk factors. Women are particularly at risk of this condition because of pregnancy, the use of combined oral contraceptive pills, and hormone replacement therapy. A number of long-term sequelae may occur following an episode of VTE in women, such as development of the post- thrombotic syndrome, restriction of future contraceptive choice, bleeding events related to anticoagulants, and recurrence of thrombosis. In recent years there has been a marked increase in our understanding of genetic risk factors important for the development of VTE, and of their interaction with acquired risks. In particular, the description of the factor V Leiden and (more recently) prothrombin 202 lOA mutations have highlighted common genetic variations that are associated with a modest increased risk of thromboembolism. These genetic mutations may also be associated with other conditions that are associated with coagulation activation, such as preeclampsia. Thrombophilia is a rapidly expanding and complex field, and undoubtedly new abnormalities will be described within the next few years."],"dc:format":["pdf"],"dc:identifier.doi":["10.5525/gla.thesis.71818"],"dc:identifier.uri":["https://theses.gla.ac.uk/71818/1/10391478.pdf"],"dc:language":["en"],"dc:publisher.department":["Department not provided."],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/71818/"],"dc:relation.isreferencedby.uri":["https://gla.on.worldcat.org/oclc/181725192"],"dc:subject":["QP Physiology"],"dcterms:accessrights":["public"],"dc:title":["Venous thrombosis and women's health: Identification of risk factors and long terms effects"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["MD"]},"updated_at":"2026-11-19T08:27:26Z"}